[Evaluation of clinical efficacy and tolerance of bepridil in patients with effort-induced angina pectoris]. 1985

C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi

UI MeSH Term Description Entries
D008297 Male Males
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias
D015764 Bepridil A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. 1978-CERM,Bedapin,Bepadin,Bepridil Monohydrochloride,Bepridil Monohydrochloride, Monohydrate,Bepridil Monohydrochloride, alpha-Isomer,Bepridil, (+)-Isomer,Bepridil, (+-)-Isomer,Bepridil, (-)-Isomer,Bepridil, alpha-Isomer,CERM-1978,Cordium,Unicordium,Vascor,1978 CERM,1978CERM,Bepridil Monohydrochloride, alpha Isomer,Bepridil, alpha Isomer,CERM 1978,CERM1978,Monohydrochloride, Bepridil,Monohydrochloride, alpha-Isomer Bepridil

Related Publications

C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
October 1991, Kardiologiia,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
December 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
May 1991, The Medical letter on drugs and therapeutics,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
September 2007, Nihon rinsho. Japanese journal of clinical medicine,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
September 1993, Journal of cardiovascular pharmacology,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
February 1986, Clinical cardiology,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
April 1992, The American journal of cardiology,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
September 1962, Folia medica Neerlandica,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
June 1987, The American journal of cardiology,
C Lai, and R Pirisi, and E Onnis, and B Tallu, and G Delogu, and A Cherchi, and M Arca, and A Cherchi
December 1989, The Tokushima journal of experimental medicine,
Copied contents to your clipboard!